TITLE:
Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

CONDITION:
Hodgkin Disease

INTERVENTION:
Filgrastim SD/01

SUMMARY:

      Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD
      chemotherapy.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 16 Years to N/A
Criteria:

        INCLUSION:

          -  Previously untreated Hodgkin's disease patients who are scheduled to receive standard
             ABVD chemo.

          -  Histologically proven diagnosis of Hodgkin's disease of any type.

          -  Bidimensionally measurable disease.

          -  Signed informed consent.

          -  Age >/= 16 yrs.

          -  Adequate bone marrow reserve (ANC>1000/uL, Platelet >100,000/uL.

          -  LVEF>/=50% by MUGA scan or echocardiogram.

          -  Serum creatinine <2mg/dL; serum bilirubin<2mg/dL.

        EXCLUSION:

          -  HIV positive.

          -  Pregnant women and those of child bearing age who are not using adequate
             contraception.

          -  Prior chemotherapy.

          -  Severe pulmonary disease including COPD and asthma.

          -  History of prior sensitivity to E.coli derived products.
      
